Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Cheryl Xu is Director at 60 Degrees Pharmaceuticals. OQRO lists 9 transactions filed with the SEC under this name, the latest on Jun 6, 2025, each linked to the official Form 4.
Director
Disclosures on record
9
Companies involved
1
2 buys, median −63.1 pts vs S&P 500, beat it 0 of 2 times.
Average −63.1 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Dec 19, 2024 to Jun 6, 2025, measured from the first close after the filing. Past results, not a forecast.
2 purchases disclosed; 0% of the 2 measured at 90 days finished ahead of the index.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
60 Degrees PharmaceuticalsSXTP
9 disclosures · Dec 2024 – Jun 2025 · 9 bought
Jun 3, 2025Bought~$8.6Kdisclosed Jun 6
DetailsOfficial recordJun 3, 2025Bought~$5.8Kdisclosed Jun 6
DetailsEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Dec 12, 2024Bought~$4.6Kdisclosed Dec 19
DetailsOfficial recordDec 12, 2024Bought~$4.5Kdisclosed Dec 19
DetailsOfficial recordDec 16, 2024Bought~$2.9Kdisclosed Dec 19
DetailsOfficial recordDec 13, 2024Bought~$2.4Kdisclosed Dec 19
DetailsOfficial recordDec 13, 2024Bought~$2.4Kdisclosed Dec 19
DetailsOfficial recordDec 13, 2024Bought~$2.3Kdisclosed Dec 19
DetailsOfficial recordDec 13, 2024Bought~$2.3Kdisclosed Dec 19
DetailsOfficial recordAs of the latest filing on , Cheryl Xu reported holding 15,816 shares of 60 Degrees Pharmaceuticals (SXTP), worth about $8.2K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals SXTP | 15,816 | 16K direct | $1 | $8.2K | Jun 3, 2025 |
Is this Cheryl Xu’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jun 3, 2025, Cheryl Xu reported holding 15,816 shares of 60 Degrees Pharmaceuticals (SXTP). At the last close of $1 on Nov 13, 2026, that is about $8.2K. This is the stake disclosed in filings, not a net worth.
Cheryl Xu bought shares on the open market in 2024 and 2025.
In SEC filings since 2024: the latest open-market purchase is from 2025; no open-market sale is on record.
60 Degrees Pharmaceuticals (SXTP), from 2024 to 2025: 11 purchases and 0 sales.
Cheryl Xu reported 11 open-market purchases and 0 sales here, 2024 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Cheryl Xu bought shares on the open market in 2024 and 2025.
Cheryl Xu reported 11 open-market purchases and 0 sales since 2024; purchases in 2 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $14K2×2 trades | — |
| 2024 | $106K9×9 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.